{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:41:04Z","timestamp":1786650064342,"version":"build-2736575974"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The recent global coronavirus disease 2019 (COVID-19) pandemic, resulting from infection by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), can cause severe and fatal pneumonia along with other life-threatening complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      The rare and limited accessibility of approved therapeutic agents or vaccines is of great distress. Swiftly working on designing and identifying inhibitors against all possible viral key protein targets, seven key SARS-CoV-2 viral enzymes were selected as targets, particularly in the action on the virus-entry, viral replication, and immune evasion of COVID-19. Papain-like protease, main protease, RNA-dependent RNA polymerase, endoribonuclease (nsp15), receptor-binding domain-angiotensin-converting enzyme 2, transmembrane serine protease 2 (TMPRSS2), and 2\u2019- O-ribose methyltransferase (2\u2032MTase), which were subjected to an unbiased\n                      <jats:italic toggle=\"yes\">in silico<\/jats:italic>\n                      screening against 22 small molecules originating from\n                      <jats:italic toggle=\"yes\">Garcinia linii<\/jats:italic>\n                      concomitantly with Remdesivir, Nirmatrelvir, and Molnupiravir were approved by Food and Drug Administration as repurposing drugs against SARS-CoV-2 invasion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic toggle=\"yes\">in silico<\/jats:italic>\n                      results showed that natural bioactive compounds containing \u03b1-Tocopheryolquinone, 6\u03b2-Hydroxystigmast-4-en-3-one, Squalene, Rutin and Quercetin have a high binding affinity with seven selected viral protein targets concurrently with the preference of absorption, distribution, metabolism, excretion, and toxicity and drug-likeness.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      This study provides potential phytoactive compounds from\n                      <jats:italic toggle=\"yes\">G<\/jats:italic>\n                      .\n                      <jats:italic toggle=\"yes\">linii<\/jats:italic>\n                      through multi-target screen with molecular dynamic simulation for combating COVID-19 pandemics that need further experimental validation to confirm the prospective efficacy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tcmj.tcmj_226_24","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T05:08:12Z","timestamp":1743829692000},"page":"275-284","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Multitarget-based in silico screening from phytoactive compounds of Garcinia linii fighting toward severe acute respiratory syndrome coronavirus-2"],"prefix":"10.4103","volume":"37","author":[{"given":"Ting-Hsu","family":"Chen","sequence":"first","affiliation":[{"name":"Graduate Institute of Brain and Mind Sciences, College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Han","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Xiamen Medical College, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May-Jywan","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Feng","family":"Weng","sequence":"additional","affiliation":[{"name":"Functional Physiology Section, Department of Basic Medical Science, Xiamen Medical College, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max K.","family":"Leong","sequence":"additional","affiliation":[{"name":"Department of Chemistry, National Dong Hwa University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"R1-20250701","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abe1202","article-title":"High-resolution structures of the SARS-CoV-2 2'- O-methyltransferase reveal strategies for structure-based inhibitor design","volume":"13","author":"Rosas-Lemus","year":"2020","journal-title":"Sci Signal"},{"key":"R2-20250701","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2577-1","article-title":"Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing","volume":"586","author":"Riva","year":"2020","journal-title":"Nature"},{"key":"R3-20250701","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"R4-20250701","doi-asserted-by":"crossref","first-page":"22398","DOI":"10.1039\/D1RA03937G","article-title":"In silico study of natural compounds from sesame against COVID-19 by targeting M (pro), PL (pro) and RdRp","volume":"11","author":"Allam","year":"2021","journal-title":"RSC Adv"},{"key":"R5-20250701","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"R6-20250701","doi-asserted-by":"crossref","first-page":"100026","DOI":"10.1016\/j.crphar.2021.100026","article-title":"Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2","volume":"2","author":"Bajad","year":"2021","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"R7-20250701","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbrc.2020.08.116","article-title":"RNA-dependent RNA polymerase:Structure, mechanism, and drug discovery for COVID-19","volume":"538","author":"Jiang","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"R8-20250701","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41467-020-20608-z","article-title":"Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamics","volume":"12","author":"Pillon","year":"2021","journal-title":"Nat Commun"},{"key":"R9-20250701","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s42003-021-01735-9","article-title":"Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2","volume":"4","author":"Kim","year":"2021","journal-title":"Commun Biol"},{"key":"R10-20250701","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/07853890.2022.2034936","article-title":"Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:A meta-analysis","volume":"54","author":"Wen","year":"2022","journal-title":"Ann Med"},{"key":"R11-20250701","doi-asserted-by":"crossref","first-page":"101489","DOI":"10.1016\/j.eclinm.2022.101489","article-title":"Baricitinib in hospitalised patients with COVID-19:A meta-analysis of randomised controlled trials","volume":"49","author":"Selvaraj","year":"2022","journal-title":"EClinicalMedicine"},{"key":"R12-20250701","doi-asserted-by":"crossref","first-page":"104146","DOI":"10.1016\/j.jff.2020.104146","article-title":"Phytochemicals containing biologically active polyphenols as an effective agent against COVID-19-inducing coronavirus","volume":"73","author":"Chojnacka","year":"2020","journal-title":"J Funct Foods"},{"key":"R13-20250701","doi-asserted-by":"crossref","first-page":"40867","DOI":"10.1039\/D0RA09010G","article-title":"Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19)","volume":"10","author":"De Vita","year":"2020","journal-title":"RSC Adv"},{"key":"R14-20250701","doi-asserted-by":"crossref","first-page":"101977","DOI":"10.1016\/j.fbio.2022.101977","article-title":"Nutraceutical prospects of Houttuynia cordata against the infectious viruses","volume":"50","author":"Ghosh","year":"2022","journal-title":"Food Biosci"},{"key":"R15-20250701","doi-asserted-by":"crossref","first-page":"27961","DOI":"10.1039\/D0RA05126H","article-title":"Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2:Identifying related therapeutic targets using network pharmacology and molecular docking analyses","volume":"10","author":"Shawky","year":"2020","journal-title":"RSC Adv"},{"key":"R16-20250701","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virol.2022.04.005","article-title":"Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E","volume":"571","author":"Zhu","year":"2022","journal-title":"Virology"},{"key":"R17-20250701","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1007\/s00203-021-02351-1","article-title":"Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by molecular docking study","volume":"203","author":"Guler","year":"2021","journal-title":"Arch Microbiol"},{"key":"R18-20250701","doi-asserted-by":"crossref","first-page":"104939","DOI":"10.1016\/j.phrs.2020.104939","article-title":"Review on the potential action mechanisms of Chinese medicines in treating coronavirus disease 2019 (COVID-19)","volume":"158","author":"Huang","year":"2020","journal-title":"Pharmacol Res"},{"key":"R19-20250701","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.2174\/1381612826999201116195851","article-title":"Natural compounds as inhibitors of SARS-CoV-2 main protease (3CLpro):A molecular docking and simulation approach to combat COVID-19","volume":"27","author":"Rehman","year":"2021","journal-title":"Curr Pharm Des"},{"key":"R20-20250701","doi-asserted-by":"crossref","first-page":"111151","DOI":"10.1016\/j.biopha.2020.111151","article-title":"Garcinia linii extracts exert the mediation of anti-diabetic molecular targets on anti-hyperglycemia","volume":"134","author":"Chen","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"R21-20250701","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1055\/s-2004-835851","article-title":"Cytotoxic xanthones and biphenyls from the root of Garcinia linii","volume":"70","author":"Chen","year":"2004","journal-title":"Planta Med"},{"key":"R22-20250701","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/10286020902964248","article-title":"Triterpenoids from the roots of Pterospermum heterophyllum Hance","volume":"11","author":"Li","year":"2009","journal-title":"J Asian Nat Prod Res"},{"key":"R23-20250701","doi-asserted-by":"crossref","first-page":"125582","DOI":"10.1016\/j.foodchem.2019.125582","article-title":"Analysis of oxidation products of \u03b1-tocopherol in extra virgin olive oil using liquid chromatography-tandem mass spectrometry","volume":"306","author":"Tanno","year":"2020","journal-title":"Food Chem"},{"key":"R24-20250701","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/cbdv.200900227","article-title":"Secondary metabolites and antimycobacterial activities from the roots of Ficus nervosa","volume":"7","author":"Chen","year":"2010","journal-title":"Chem Biodivers"},{"key":"R25-20250701","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41586-021-03530-2","article-title":"Adjuvanting a subunit COVID-19 vaccine to induce protective immunity","volume":"594","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"R27-20250701","doi-asserted-by":"crossref","first-page":"e2100123","DOI":"10.1002\/ardp.202100123","article-title":"Garcinol from Garcinia indica inhibits HIV-1 reverse transcriptase-associated ribonuclease H","volume":"354","author":"Corona","year":"2021","journal-title":"Arch Pharm (Weinheim)"},{"key":"R28-20250701","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/vim.2015.0013","article-title":"Kolaviron improves morbidity and suppresses mortality by mitigating oxido-inflammation in BALB\/c mice infected with influenza virus","volume":"28","author":"Awogbindin","year":"2015","journal-title":"Viral Immunol"},{"key":"R29-20250701","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.1007\/s12035-015-9543-1","article-title":"Antimalarial drug artemether inhibits neuroinflammation in BV2 microglia through Nrf2-dependent mechanisms","volume":"53","author":"Okorji","year":"2016","journal-title":"Mol Neurobiol"},{"key":"R30-20250701","doi-asserted-by":"crossref","first-page":"101166","DOI":"10.1016\/j.redox.2019.101166","article-title":"The Vitamin E derivative garcinoic acid from Garcinia kola nut seeds attenuates the inflammatory response","volume":"24","author":"Wallert","year":"2019","journal-title":"Redox Biol"},{"key":"R31-20250701","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.virusres.2017.08.011","article-title":"Alpha-mangostin inhibits both dengue virus production and cytokine\/chemokine expression","volume":"240","author":"Tarasuk","year":"2017","journal-title":"Virus Res"},{"key":"R32-20250701","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jiph.2022.11.022","article-title":"The exploration of phytocompounds theoretically combats SARS-CoV-2 pandemic against virus entry, viral replication and immune evasion","volume":"16","author":"Chen","year":"2023","journal-title":"J Infect Public Health"},{"key":"R33-20250701","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.3390\/molecules28207160","article-title":"Role of computer-aided drug design in drug development","volume":"28","author":"Gu","year":"2023","journal-title":"Molecules"},{"key":"R34-20250701","doi-asserted-by":"crossref","first-page":"112268","DOI":"10.1016\/j.jep.2019.112268","article-title":"In silico screening of potential antidiabetic phytochemicals from Phyllanthus emblica against therapeutic targets of type 2 diabetes","volume":"248","author":"Sharma","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"R35-20250701","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR:A comprehensive source and free tool for assessment of chemical ADMET properties","volume":"52","author":"Cheng","year":"2012","journal-title":"J Chem Inf Model"},{"key":"R36-20250701","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J Mol Biol"},{"key":"R37-20250701","doi-asserted-by":"crossref","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R38-20250701","doi-asserted-by":"crossref","first-page":"9871","DOI":"10.33263\/BRIAC113.98719879","article-title":"Molecular docking studies of flavonoids from andrographis paniculata as potential acetylcholinesterase, butyrylcholinesterase and monoamine oxidase inhibitors towards the treatment of neurodegenerative diseases","volume":"11","author":"Ishola","year":"2020","journal-title":"Biointerface Res Appl Chem"},{"key":"R39-20250701","doi-asserted-by":"crossref","first-page":"730288","DOI":"10.3389\/fcimb.2021.730288","article-title":"Identification of natural inhibitors against SARS-CoV-2 drugable targets using molecular docking, molecular dynamics simulation, and MM-PBSA approach","volume":"11","author":"Kushwaha","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"R40-20250701","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41401-020-0483-6","article-title":"Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients","volume":"41","author":"Su","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"R41-20250701","doi-asserted-by":"crossref","first-page":"eabd4596","DOI":"10.1126\/sciadv.abd4596","article-title":"Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease:A framework for anti-COVID-19 drug design","volume":"6","author":"Rut","year":"2020","journal-title":"Sci Adv"},{"key":"R42-20250701","doi-asserted-by":"crossref","first-page":"e2021946118","DOI":"10.1073\/pnas.2021946118","article-title":"Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP","volume":"118","author":"Naydenova","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R43-20250701","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"R44-20250701","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41589-022-01059-7","article-title":"Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation","volume":"18","author":"Fraser","year":"2022","journal-title":"Nat Chem Biol"},{"key":"R45-20250701","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/molecules22010136","article-title":"The performance of several docking programs at reproducing protein-macrolide-like crystal structures","volume":"22","author":"Castro-Alvarez","year":"2017","journal-title":"Molecules"},{"key":"R46-20250701","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/thoraxjnl-2020-216086","article-title":"Patient outcomes after hospitalisation with COVID-19 and implications for follow-up:Results from a prospective UK cohort","volume":"76","author":"Arnold","year":"2021","journal-title":"Thorax"},{"key":"R47-20250701","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.00375.2021","article-title":"Long-term complications of COVID-19","volume":"322","author":"Desai","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"R48-20250701","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.dsx.2020.12.025","article-title":"Long COVID-19:Challenges in the diagnosis and proposed diagnostic criteria","volume":"15","author":"Raveendran","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"R49-20250701","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1164\/rccm.201111-2025OC","article-title":"The adult respiratory distress syndrome cognitive outcomes study:Long-term neuropsychological function in survivors of acute lung injury","volume":"185","author":"Mikkelsen","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R50-20250701","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jpsychires.2020.06.022","article-title":"The landscape of cognitive function in recovered COVID-19 patients","volume":"129","author":"Zhou","year":"2020","journal-title":"J Psychiatr Res"},{"key":"R51-20250701","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13195-020-00640-3","article-title":"Immediate and long-term consequences of COVID-19 infections for the development of neurological disease","volume":"12","author":"Heneka","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"R52-20250701","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00415-021-10655-x","article-title":"Long COVID:Cognitive complaints (brain fog) and dysfunction of the cingulate cortex","volume":"269","author":"Hugon","year":"2022","journal-title":"J Neurol"},{"key":"R53-20250701","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbi.2020.07.037","article-title":"Anxiety and depression in COVID-19 survivors:Role of inflammatory and clinical predictors","volume":"89","author":"Mazza","year":"2020","journal-title":"Brain Behav Immun"},{"key":"R54-20250701","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12519-021-00457-6","article-title":"Long COVID in children and adolescents","volume":"17","author":"Asadi-Pooya","year":"2021","journal-title":"World J Pediatr"},{"key":"R55-20250701","doi-asserted-by":"crossref","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 among children in China","volume":"145","author":"Dong","year":"2020","journal-title":"Pediatrics"},{"key":"R56-20250701","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/cid\/ciaa1044","article-title":"Systematic severe acute respiratory syndrome coronavirus 2 screening at hospital admission in children:A French prospective multicenter study","volume":"72","author":"Poline","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R57-20250701","first-page":"107","article-title":"Acute transverse myelitis of childhood due to novel coronavirus disease 2019:The first pediatric case report and review of literature","volume":"15","author":"Nejad Biglari","year":"2021","journal-title":"Iran J Child Neurol"},{"key":"R58-20250701","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.arcmed.2021.03.010","article-title":"Post-COVID syndrome:Incidence, clinical spectrum, and challenges for primary healthcare professionals","volume":"52","author":"Pavli","year":"2021","journal-title":"Arch Med Res"},{"key":"R59-20250701","first-page":"2050","article-title":"Microbial synthesis of plant polyphenols","volume":"37","author":"Li","year":"2021","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"R60-20250701","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.3390\/molecules25235690","article-title":"Phytochemicals and biological activities of Garcinia morella (Gaertn.). Desr:A review","volume":"25","author":"Murthy","year":"2020","journal-title":"Molecules"},{"key":"R61-20250701","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.2147\/DDDT.S321824","article-title":"Effectiveness and anticancer activity of a novel phenolic compound from Garcinia porrecta against the MCF-7 breast cancer cell line in vitro and in silico","volume":"15","author":"Darwati","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"R62-20250701","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.3390\/molecules25194513","article-title":"Medicinal potential of Garcinia species and their compounds","volume":"25","author":"Espirito Santo","year":"2020","journal-title":"Molecules"},{"key":"R63-20250701","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/biom9110641","article-title":"The exploration of natural compounds for anti-diabetes from distinctive species Garcinia linii with comprehensive review of the Garcinia family","volume":"9","author":"Chen","year":"2019","journal-title":"Biomolecules"},{"key":"R64-20250701","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-2005-916253","article-title":"Benzopyrans, biphenyls and xanthones from the root of Garcinia linii and their activity against Mycobacterium tuberculosis","volume":"72","author":"Chen","year":"2006","journal-title":"Planta Med"},{"key":"R65-20250701","doi-asserted-by":"crossref","first-page":"58628","DOI":"10.1007\/s11356-022-21652-6","article-title":"Propolis efficacy on SARS-COV viruses:A review on antimicrobial activities and molecular simulations","volume":"29","author":"Ghosh","year":"2022","journal-title":"Environ Sci Pollut Res Int"},{"key":"R66-20250701","doi-asserted-by":"crossref","first-page":"12636","DOI":"10.3390\/ijerph182312636","article-title":"\u03b2-Glucans could be adjuvants for SARS-CoV-2 virus vaccines (COVID-19)","volume":"18","author":"C\u00f3rdova-Mart\u00ednez","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"R67-20250701","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13068-022-02208-9","article-title":"Metabolic recycling of storage lipids promotes squalene biosynthesis in yeast","volume":"15","author":"Son","year":"2022","journal-title":"Biotechnol Biofuels Bioprod"},{"key":"R68-20250701","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41421-021-00249-2","article-title":"SARS-CoV-2 cell tropism and multiorgan infection","volume":"7","author":"Liu","year":"2021","journal-title":"Cell Discov"},{"key":"R69-20250701","doi-asserted-by":"crossref","first-page":"e202000786","DOI":"10.26508\/lsa.202000786","article-title":"TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells","volume":"3","author":"Bestle","year":"2020","journal-title":"Life Sci Alliance"},{"key":"R70-20250701","doi-asserted-by":"crossref","first-page":"e1009233","DOI":"10.1371\/journal.ppat.1009233","article-title":"SARS-CoV-2 variants with mutations at the S1\/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells","volume":"17","author":"Sasaki","year":"2021","journal-title":"PLoS Pathog"},{"key":"R71-20250701","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s12035-021-02696-0","article-title":"Could SARS-CoV-2 spike protein be responsible for long-COVID syndrome?","volume":"59","author":"Theoharides","year":"2022","journal-title":"Mol Neurobiol"},{"key":"R72-20250701","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3390\/jpm11090860","article-title":"Ways to address perinatal mast cell activation and focal brain inflammation, including response to SARS-CoV-2, in autism spectrum disorder","volume":"11","author":"Theoharides","year":"2021","journal-title":"J Pers Med"},{"key":"R73-20250701","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/22221751.2020.1870414","article-title":"SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1):Implications for disease presentation across species","volume":"10","author":"Moustaqil","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"R74-20250701","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1017\/neu.2022.6","article-title":"Long COVID, neuropsychiatric disorders, psychotropics, present and future","volume":"34","author":"Tang","year":"2022","journal-title":"Acta Neuropsychiatr"},{"key":"R75-20250701","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/pharmaceutics15010049","article-title":"A guide to in silico drug design","volume":"15","author":"Chang","year":"2022","journal-title":"Pharmaceutics"},{"key":"R76-20250701","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"R77-20250701","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrd1799","article-title":"Computer-based de novo design of drug-like molecules","volume":"4","author":"Schneider","year":"2005","journal-title":"Nat Rev Drug Discov"}],"container-title":["Tzu Chi Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_226_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:01:38Z","timestamp":1786647698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_226_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/tcmj.tcmj_226_24","relation":{},"ISSN":["1016-3190","2223-8956"],"issn-type":[{"value":"1016-3190","type":"print"},{"value":"2223-8956","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"assertion":[{"value":"2024-09-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}